Clearside Biomedical, Inc.
US ˙ NasdaqGM ˙ US1850631045

Pendahuluan

Halaman ini memberikan analisis komprehensif tentang sejarah perdagangan orang dalam yang diketahui dari Clay Thorp. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Adalah ilegal bagi orang dalam untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik yang tidak dipublikasikan. Ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan kepada SEC melalui Formulir 4. Terlepas dari pembatasan ini, penelitian akademis menunjukkan bahwa orang dalam - secara umum - cenderung mengungguli pasar di perusahaan mereka sendiri.

Rata-rata Profitabilitas Perdagangan

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari semua pembelian pasar terbuka yang dilakukan oleh orang dalam dalam tiga tahun terakhir. Untuk menghitung ini, kami memeriksa setiap pembelian pasar terbuka yang tidak direncanakan yang dilakukan oleh orang dalam, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata dari perdagangan tersebut selama 3, 6, dan 12 bulan, dengan merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami merata-ratakan semua metrik kinerja untuk menghitung metrik kinerja untuk orang dalam. Daftar ini hanya mencakup orang dalam yang telah melakukan setidaknya tiga perdagangan dalam dua tahun terakhir.

Jika profitabilitas perdagangan orang dalam ini adalah "N/A", maka orang dalam tersebut belum melakukan pembelian di pasar terbuka dalam tiga tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang andal.

Frekuensi Pembaruan: Setiap Hari

Lihat daftar pedagang dalam perusahaan yang paling menguntungkan.

Perusahaan dengan Posisi Orang Dalam yang Dilaporkan

Pengajuan SEC menunjukkan bahwa Clay Thorp telah melaporkan kepemilikan atau perdagangan di perusahaan-perusahaan berikut:

Keamanan Judul Kepemilikan Terakhir yang Dilaporkan
US:CLSD / Clearside Biomedical, Inc. Director 176,141
US:PHAS / PhaseBio Pharmaceuticals Inc Director 36,693
US:VIGL / Vigil Neuroscience, Inc. Director 1,556,030
US:GTHX / G1 Therapeutics, Inc. 10% Owner 3,237,711
Cara Membaca Grafik

Grafik berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka yang tidak direncanakan yang dilakukan oleh Clay Thorp. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham digambarkan sebagai perubahan persentase kumulatif dalam harga saham. Misalnya, jika perdagangan orang dalam dilakukan pada 1 Januari 2019, grafik akan menunjukkan perubahan persentase harian sekuritas hingga saat ini. Jika harga saham naik dari $10 menjadi $15 selama periode ini, perubahan persentase kumulatif dalam harga saham akan menjadi 50%. Perubahan harga dari $10 menjadi $20 akan menjadi 100%, dan perubahan harga dari $10 menjadi $5 akan menjadi -50%.

Pada akhirnya, kita mencoba menentukan seberapa erat korelasi perdagangan orang dalam dengan pengembalian berlebih (positif atau negatif) pada harga saham untuk melihat apakah orang dalam tersebut mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi orang dalam. Pertimbangkan situasi di mana orang dalam melakukan hal ini. Dalam situasi ini, kita akan mengharapkan (a) pengembalian positif setelah pembelian, atau (b) pengembalian negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, menunjukkan pengembalian positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, menunjukkan pengembalian negatif setelah setiap transaksi penjualan.

Namun, ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam tren kenaikan non-siklikal selama bertahun-tahun, maka kita akan mengharapkan semua plot pasca-pembelian memiliki kemiringan ke atas. Demikian pula, penurunan non-siklikal selama bertahun-tahun akan menghasilkan plot pasca-perdagangan dengan kemiringan ke bawah. Tak satu pun dari grafik ini akan menunjukkan aktivitas perdagangan orang dalam.

Indikator terkuat adalah situasi di mana harga saham sangat siklikal, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat menunjukkan adanya orang dalam yang mengatur waktu perdagangan untuk keuntungan finansial mereka.

Pembelian Orang Dalam CLSD / Clearside Biomedical, Inc. - Analisis Keuntungan Jangka Pendek

Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CLSD / Clearside Biomedical, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Maksimum Pengembalian (%)
2025-02-24 CLSD Thorp Clay 15,000 0.9200 15,000 0.9200 13,800 28 1.0300 1,650 11.96
2023-09-25 CLSD Thorp Clay 10,000 0.8600 10,000 0.8600 8,600
2022-12-21 CLSD Thorp Clay 14,000 1.0190 14,000 1.0190 14,266
2018-12-06 CLSD Thorp Clay 8,000 1.3600 8,000 1.3600 10,880
2016-06-07 CLSD Hatteras Venture Advisors IV SBIC, LLC 414,286 7.0000 414,286 7.0000 2,900,002
2016-06-07 CLSD Hatteras Venture Advisors III, LLC 107,142 7.0000 107,142 7.0000 749,994
2016-06-07 CLSD Thorp Clay 785,714 7.0000 785,714 7.0000 5,499,998

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

CLSD / Clearside Biomedical, Inc. Insider Trades
Penjualan Orang Dalam CLSD / Clearside Biomedical, Inc. - Analisis Kerugian Jangka Pendek

Pada bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan internal pasar terbuka yang tidak direncanakan yang dilakukan di CLSD / Clearside Biomedical, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Ticker Orang Dalam Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari-hari menuju
Menit
Harga di
Menit
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2018-05-18 CLSD Thorp Clay 61,139 13.1600 61,139 13.1600 804,589 217 1.0000 -743,450 -92.40
2018-05-17 CLSD Thorp Clay 100,000 13.0300 100,000 13.0300 1,303,000
2018-03-23 CLSD Thorp Clay 5,231 12.0200 5,231 12.0200 62,877
2018-03-22 CLSD Thorp Clay 33,630 12.0700 33,630 12.0700 405,914
2018-03-21 CLSD Thorp Clay 100,000 12.2700 100,000 12.2700 1,227,000
2017-01-19 CLSD Hatteras Venture Advisors IV SBIC, LLC 7,592 8.2200 7,592 8.2200 62,406
2017-01-19 CLSD Hatteras Venture Advisors III, LLC 6,478 8.2200 6,478 8.2200 53,249
2017-01-18 CLSD Hatteras Venture Advisors IV SBIC, LLC 12,258 8.6400 12,258 8.6400 105,909
2017-01-18 CLSD Hatteras Venture Advisors III, LLC 10,457 8.6400 10,457 8.6400 90,348
2017-01-17 CLSD Hatteras Venture Advisors IV SBIC, LLC 9,806 8.9200 9,806 8.9200 87,470
2017-01-17 CLSD Hatteras Venture Advisors III, LLC 8,366 8.9200 8,366 8.9200 74,625
2016-06-07 CLSD Hatteras Venture Advisors IV SBIC, LLC 69 7.0000 69 7.0000 483
2016-06-07 CLSD Hatteras Venture Advisors III, LLC 69 7.0000 69 7.0000 483
2016-06-07 CLSD Thorp Clay 138 7.0000 138 7.0000 966

Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pemisahan saham.

CLSD / Clearside Biomedical, Inc. Insider Trades
Sejarah Perdagangan Orang Dalam

Tabel ini menunjukkan daftar lengkap transaksi orang dalam yang dilakukan oleh Clay Thorp sebagaimana diungkapkan kepada Komisi Bursa Efek (Securities Exchange Commission/SEC).

Tanggal File Tanggal Transaksi Formulir Ticker Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Ubah
Bagikan
Harga
Tran
Nilai
Sisa
Nilai
2025-02-24 2025-02-24 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 15,000 176,141 9.31 0.92 13,800 162,050
2023-09-25 2023-09-25 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 10,000 40,522 32.76 0.86 8,600 34,849
2023-05-19 2023-05-19 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
M - Exercise 3,750 36,693 11.38
2022-12-21 2022-12-21 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 14,000 30,522 84.74 1.02 14,266 31,102
2022-12-19 2021-02-10 4/A CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -32,873 4,951,547 -0.66 4.43 -145,627 21,935,353
2022-12-19 2022-12-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
J - Other 8,522 16,522 106.52
2022-12-19 2022-12-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
J - Other -1,406,507 3,545,040 -28.41
2022-05-20 2022-05-19 4 PHAS PhaseBio Pharmaceuticals Inc
Restricted Stock Units
A - Award 3,750 3,750
2022-05-20 2022-05-19 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 17,500 17,500
2022-05-17 2022-05-17 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 14,893 1,556,030 0.97 2.97 44,189 4,616,897
2022-05-17 2022-05-16 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 21,802 1,541,137 1.43 2.76 60,221 4,256,929
2022-03-28 2022-03-28 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 3,000 3,000 7.20 21,604 21,604
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Series B Preferred Stock
C - Conversion -926,506 0 -100.00
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Series A Preferred Stock
C - Conversion -2,552,021 0 -100.00
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Common Stock
P - Purchase 265,000 1,519,335 21.13 14.00 3,710,000 21,270,690
2022-01-11 2022-01-11 4 VIGL Vigil Neuroscience, Inc.
Common Stock
C - Conversion 1,254,335 1,254,335
2021-08-18 2021-08-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 10,000 32,943 43.59 3.00 30,000 98,829
2021-06-11 2021-06-10 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 25,000 25,000
2021-06-04 2021-06-03 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 14,000 14,000
2021-02-12 2021-02-10 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -32,873 3,433,521 -0.95 4.43 -145,627 15,210,498
2020-11-24 2020-11-24 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 2,000 22,943 9.55 3.50 7,000 80,300
2020-11-24 2020-11-23 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 3,000 20,943 16.72 3.67 11,010 76,861
2020-11-18 2020-11-16 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
J - Other 10,586 15,432 218.45
2020-11-18 2020-11-16 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
J - Other 2,144 17,943 13.57
2020-11-18 2020-11-16 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
J - Other -52,397 0 -100.00
2020-06-19 2020-06-18 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 25,000 25,000
2020-06-05 2020-06-03 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 16,000 16,000
2019-11-26 2019-11-22 4 CLSD Clearside Biomedical, Inc.
Common Stock
A - Award 1,518,026 4,984,420 43.79 1.05 1,599,999 5,253,579
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -459 415,959 -0.11 14.00 -6,426 5,823,426
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -255 52,397 -0.48 14.00 -3,570 733,558
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -180 162,890 -0.11 14.00 -2,520 2,280,460
2019-07-03 2019-07-01 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -2,014 1,818,638 -0.11 14.00 -28,196 25,460,932
2019-06-24 2019-06-20 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 20,000 20,000
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -63 416,418 -0.02 14.00 -882 5,829,852
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -35 52,655 -0.07 14.00 -490 737,170
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -25 163,074 -0.02 14.00 -350 2,283,036
2019-06-20 2019-06-18 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
S - Sale X -277 1,820,656 -0.02 14.00 -3,878 25,489,184
2019-05-13 2019-05-09 4 PHAS PhaseBio Pharmaceuticals Inc
Non-employee Director Stock Option (right to buy)
A - Award 11,000 11,000
2019-03-01 2019-02-27 4 PHAS PhaseBio Pharmaceuticals Inc
Employee Stock Option (right to buy)
A - Award 36,000 36,000
2018-12-06 2018-12-04 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 4,000 15,799 33.90 3.13 12,520 49,451
2018-12-06 2018-12-06 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 8,000 8,000 1.36 10,880 10,880
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -226,061 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -24,709 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series D Preferred Stock
C - Conversion -272,107 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -40,420 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -13,558 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
C - Conversion -149,320 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -94,874 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
C - Conversion -1,044,764 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
C - Conversion -13,609 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series AA Preferred Stock
C - Conversion -174,699 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -4,846 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -3,862 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -42,530 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series 1 Preferred Stock
C - Conversion -52,690 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -994 40,420 -2.40 5.00 -4,970 202,100
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
M - Exercise 41,414 41,414 0.12 4,970 4,970
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
M - Exercise -41,414 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -104 13,558 -0.76 5.00 -520 67,790
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
M - Exercise 4,309 13,662 46.07 0.12 517 1,639
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
M - Exercise -4,309 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
S - Sale -1,139 149,320 -0.76 5.00 -5,695 746,600
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series C-1 Preferred Stock
M - Exercise 47,458 150,459 46.08 0.12 5,695 18,055
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series C-1 Preferred Stock
M - Exercise -47,458 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
S - Sale -42 94,874 -0.04 5.00 -210 474,370
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
M - Exercise 1,731 94,916 1.86 0.12 208 11,390
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
M - Exercise -1,731 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
S - Sale -458 1,044,764 -0.04 5.00 -2,290 5,223,820
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Series B Preferred Stock
M - Exercise 19,061 1,045,222 1.86 0.12 2,287 125,427
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Warrants to Purchase Series B Preferred Stock
M - Exercise -19,061 0 -100.00
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 150,000 416,481 56.29 5.00 750,000 2,082,405
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 266,481 266,481
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 4,846 4,846
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 12,487 163,099 8.29 5.00 62,435 815,495
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 150,612 150,612
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
P - Purchase 137,513 1,820,933 8.17 5.00 687,565 9,104,665
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 1,683,420 1,683,420
2018-10-24 2018-10-22 4 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
C - Conversion 52,690 52,690
2018-10-17 3 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
23,598
2018-10-17 3 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
23,598
2018-10-17 3 PHAS PhaseBio Pharmaceuticals Inc
Common Stock
23,598
2018-06-21 2018-06-20 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 11,250 11,250
2018-06-01 2018-05-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -41,710 3,237,711 -1.27 48.00 -2,002,080 155,410,128
2018-06-01 2018-05-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -758,290 3,279,421 -18.78 48.00 -36,397,920 157,412,208
2018-05-23 2018-05-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -26 4,037,711 0.00 50.50 -1,313 203,904,406
2018-05-23 2018-05-23 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -474 4,037,737 -0.01 50.50 -23,937 203,905,718
2018-05-23 2018-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -308 4,038,211 -0.01 50.69 -15,611 204,677,128
2018-05-23 2018-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -5,592 4,038,519 -0.14 50.86 -284,405 205,396,249
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -26 4,044,111 0.00 52.13 -1,355 210,819,506
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -474 4,044,137 -0.01 52.13 -24,710 210,820,862
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -1,595 4,044,611 -0.04 51.06 -81,439 206,513,389
2018-05-23 2018-05-21 4 GTHX G1 Therapeutics, Inc.
Common Stock
S - Sale -29,005 4,046,206 -0.71 51.16 -1,483,907 207,005,517
2018-05-21 2018-05-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -61,139 3,466,394 -1.73 13.16 -804,589 45,617,745
2018-05-21 2018-05-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -100,000 3,527,533 -2.76 13.03 -1,303,000 45,963,755
2018-03-23 2018-03-23 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -5,231 3,627,533 -0.14 12.02 -62,877 43,602,947
2018-03-23 2018-03-22 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -33,630 3,632,764 -0.92 12.07 -405,914 43,847,461
2018-03-23 2018-03-21 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -100,000 3,666,394 -2.66 12.27 -1,227,000 44,986,654
2017-12-07 2017-12-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -5,000 3,766,394 -0.13 6.13 -30,650 23,087,995
2017-12-07 2017-12-06 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,771,394 -0.40 6.09 -91,350 22,967,789
2017-12-07 2017-12-05 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,786,394 -0.39 6.37 -95,550 24,119,330
2017-12-04 2017-11-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
J - Other 995 4,075,211 0.02
2017-12-04 2017-11-30 4 GTHX G1 Therapeutics, Inc.
Common Stock
J - Other -99,513 4,074,216 -2.38
2017-11-16 2017-11-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -5,000 3,801,394 -0.13 6.99 -34,950 26,571,744
2017-11-16 2017-11-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,806,394 -0.39 6.99 -104,850 26,606,694
2017-11-16 2017-11-14 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,821,394 -0.39 7.02 -105,300 26,826,186
2017-10-05 2017-10-05 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -6,000 3,836,394 -0.16 8.34 -50,040 31,995,526
2017-10-05 2017-10-04 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -14,000 3,842,394 -0.36 8.59 -120,260 33,006,164
2017-10-05 2017-10-03 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,856,394 -0.39 8.64 -129,600 33,319,244
2017-09-15 2017-09-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -10,000 3,871,394 -0.26 7.54 -75,400 29,190,311
2017-09-15 2017-09-14 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -6,000 3,881,394 -0.15 7.52 -45,120 29,188,083
2017-09-15 2017-09-13 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -8,500 3,887,394 -0.22 7.49 -63,665 29,116,581
2017-08-09 2017-08-09 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,895,894 -0.38 7.30 -109,500 28,440,026
2017-08-09 2017-08-08 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -5,000 3,910,894 -0.13 7.98 -39,900 31,208,934
2017-08-09 2017-08-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -4,500 3,915,894 -0.11 8.02 -36,090 31,405,470
2017-07-05 2017-06-30 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 2,632 2,632
2017-06-23 2017-06-22 4 CLSD Clearside Biomedical, Inc.
Stock Option (right to buy)
A - Award 8,618 8,618
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series C Preferred Stock
C - Conversion -1,009,693 0 -100.00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -2,584,959 0 -100.00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -6,568,527 0 -100.00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Series 1 Preferred Stock
C - Conversion -1,318,681 0 -100.00
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
P - Purchase 133,333 3,861,797 3.58 15.00 1,999,995 57,926,955
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 99,513 99,513
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 212,419 212,419
2017-05-24 2017-05-22 4 GTHX G1 Therapeutics, Inc.
Common Stock
C - Conversion 3,728,464 3,728,464
2017-05-19 2017-05-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,000 3,920,394 -0.38 8.31 -124,650 32,578,474
2017-05-19 2017-05-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -9,000 3,935,394 -0.23 8.44 -75,960 33,214,725
2017-05-17 2017-05-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -19,000 3,944,394 -0.48 8.39 -159,410 33,093,466
2017-05-17 2017-05-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -9,544 3,963,394 -0.24 8.61 -82,174 34,124,822
2017-05-17 2017-05-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,941 3,972,938 -0.40 8.94 -142,513 35,518,066
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
413,041
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
226,301
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
413,041
2017-05-17 3 GTHX G1 Therapeutics, Inc.
Common Stock
226,301
2017-04-19 2017-04-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -2,030 3,988,879 -0.05 7.37 -14,961 29,398,038
2017-04-19 2017-04-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -44,455 3,990,909 -1.10 7.48 -332,523 29,851,999
2017-04-19 2017-04-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -22,000 4,035,364 -0.54 7.43 -163,460 29,982,755
2017-03-17 2017-03-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -21,485 4,057,364 -0.53 6.77 -145,453 27,468,354
2017-03-17 2017-03-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -47,000 4,078,849 -1.14 6.47 -304,090 26,390,153
2017-02-22 2017-02-22 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -2,000 4,125,849 -0.05 7.49 -14,980 30,902,609
2017-02-22 2017-02-21 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -25,000 4,127,849 -0.60 7.55 -188,750 31,165,260
2017-02-17 2017-02-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -10,000 4,152,849 -0.24 7.54 -75,400 31,312,481
2017-02-17 2017-02-16 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -14,000 4,162,849 -0.34 7.58 -106,120 31,554,395
2017-02-17 2017-02-15 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -17,485 4,176,849 -0.42 7.64 -133,585 31,911,126
2017-01-20 2017-01-20 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -8,000 4,194,334 -0.19 7.77 -62,160 32,589,975
2017-01-20 2017-01-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -15,485 4,202,334 -0.37 8.23 -127,442 34,585,209
2017-01-20 2017-01-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -25,000 4,217,819 -0.59 8.64 -216,000 36,441,956
2017-01-20 2017-01-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale X -20,000 4,242,819 -0.47 8.92 -178,400 37,845,945
2017-01-19 2017-01-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -7,592 2,060,514 -0.37 8.22 -62,406 16,937,425
2017-01-19 2017-01-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -12,258 2,068,106 -0.59 8.64 -105,909 17,868,436
2017-01-19 2017-01-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -9,806 2,080,364 -0.47 8.92 -87,470 18,556,847
2017-01-19 2017-01-19 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -6,478 1,757,719 -0.37 8.22 -53,249 14,448,450
2017-01-19 2017-01-18 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -10,457 1,764,197 -0.59 8.64 -90,348 15,242,662
2017-01-19 2017-01-17 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -8,366 1,774,654 -0.47 8.92 -74,625 15,829,914
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -21,705 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series C Preferred Stock
C - Conversion -337,897 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series B Preferred Stock
C - Conversion -432,941 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A-1 Preferred Stock
C - Conversion -689,388 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A Preferred Stock
C - Conversion -2,035,908 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 414,286 2,090,170 24.72 7.00 2,900,002 14,631,190
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -69 1,675,884 0.00 7.00 -483 11,731,188
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
X - Other 21,705 1,675,953 1.31 0.02 478 36,871
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
C - Conversion 1,598,223 1,654,248 2,852.70
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,805 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -19,900 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series C Preferred Stock
C - Conversion -337,898 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series B Preferred Stock
C - Conversion -432,940 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A-1 Preferred Stock
C - Conversion -689,388 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A Preferred Stock
C - Conversion -2,035,907 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 107,142 1,783,020 6.39 7.00 749,994 12,481,140
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -69 1,675,878 0.00 7.00 -483 11,731,146
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
X - Other 21,705 1,675,947 1.31 0.02 478 36,871
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
C - Conversion 1,598,219 1,654,242 2,852.79
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -21,705 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -1,805 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Warrant to Purchase Common Stock (right to buy)
X - Other -19,900 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series C Preferred Stock
C - Conversion -675,795 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series B Preferred Stock
C - Conversion -865,881 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A-1 Preferred Stock
C - Conversion -1,654,531 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Series A Preferred Stock
C - Conversion -4,071,815 0 -100.00
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
P - Purchase 785,714 4,262,819 22.60 7.00 5,499,998 29,839,733
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
S - Sale -138 3,477,105 0.00 7.00 -966 24,339,735
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
X - Other 43,410 3,477,243 1.26 0.02 955 76,499
2016-06-07 2016-06-07 4 CLSD Clearside Biomedical, Inc.
Common Stock
C - Conversion 3,321,785 3,433,833 2,964.61
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
224,096
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
224,096
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,050
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
2016-06-01 3 CLSD Clearside Biomedical, Inc.
Common Stock
112,046
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)